Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
Genet Med. 2010 Nov;12(11):742-5. doi: 10.1097/GIM.0b013e3181f8baad.
Laboratory evaluation of patients with developmental delay/intellectual disability, congenital anomalies, and dysmorphic features has changed significantly in the last several years with the introduction of microarray technologies. Using these techniques, a patient's genome can be examined for gains or losses of genetic material too small to be detected by standard G-banded chromosome studies. This increased resolution of microarray technology over conventional cytogenetic analysis allows for identification of chromosomal imbalances with greater precision, accuracy, and technical sensitivity. A variety of array-based platforms are now available for use in clinical practice, and utilization strategies are evolving. Thus, a review of the utility and limitations of these techniques and recommendations regarding present and future application in the clinical setting are presented in this study.
近年来,随着微阵列技术的引入,对发育迟缓/智力残疾、先天性异常和发育不良特征的患者进行实验室评估发生了重大变化。使用这些技术,可以检查患者的基因组是否存在太小而无法通过标准 G 带染色体研究检测到的遗传物质的增益或损失。与传统细胞遗传学分析相比,微阵列技术的这种分辨率提高使得能够更精确、准确和技术灵敏地识别染色体不平衡。现在有多种基于阵列的平台可用于临床实践,并且正在不断发展利用策略。因此,本研究综述了这些技术的实用性和局限性,并就其在临床环境中的当前和未来应用提出了建议。